Asymptomatic bacteriuria Escherichia coli strains:: adhesins, growth and competition

被引:62
作者
Roos, Viktoria
Nielsen, Eva M.
Klemm, Per
机构
[1] Tech Univ Denmark, BioCentrum, Ctr Biomed Microbiol, Adhes Grp, DK-2800 Lyngby, Denmark
[2] State Serum Inst, Dept Bacteriol Mycol & Parasitol, Copenhagen S, Denmark
关键词
ABU; adhesins; asymptomatic bacteriuria; growth-competition; urinary tract infection; urine growth;
D O I
10.1111/j.1574-6968.2006.00355.x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Urinary tract infections (UTIs) affect millions of people each year. Escherichia coli is the most common organism associated with asymptomatic bacteriuria (ABU) in humans. Persons affected by ABU may carry a particular E. coli strain for extended periods of time without any symptoms. In contrast to uropathogenic E. coli (UPEC) that cause symptomatic UTI, very little is known about the mechanisms by which these strains colonize the urinary tract. Here, we have investigated the growth characteristics in human urine as well as adhesin repertoire of nine ABU strains; the ability of ABU strains to compete against the UPEC strain CFT073 was also studied. The different ABU strains displayed a wide variety of the measured characteristics. Half of the ABU strains displayed functional type 1 fimbriae while only one expressed functional P fimbriae. A good correlation between the growth rate of a particular strain and the survival of the strain in competition against CFT073 was observed. Our results support the notion that for strains with reduced capacity to express fimbriae, the ability to grow fast in human urine becomes crucial for colonization of the urinary tract.
引用
收藏
页码:22 / 30
页数:9
相关论文
共 39 条
[1]   PERSISTENCE OF ESCHERICHIA-COLI BACTERIURIA IS NOT DETERMINED BY BACTERIAL ADHERENCE [J].
ANDERSSON, P ;
ENGBERG, I ;
LIDINJANSON, G ;
LINCOLN, K ;
HULL, R ;
HULL, S ;
SVANBORG, C .
INFECTION AND IMMUNITY, 1991, 59 (09) :2915-2921
[2]   MOLECULAR EPIDEMIOLOGY OF ADHESIN AND HEMOLYSIN VIRULENCE FACTORS AMONG UROPATHOGENIC ESCHERICHIA-COLI [J].
ARTHUR, M ;
JOHNSON, CE ;
RUBIN, RH ;
ARBEIT, RD ;
CAMPANELLI, C ;
KIM, C ;
STEINBACH, S ;
AGARWAL, M ;
WILKINSON, R ;
GOLDSTEIN, R .
INFECTION AND IMMUNITY, 1989, 57 (02) :303-313
[3]  
Bachmann B.B.J., 1996, DERIVATION GENOTYPES, P2460
[4]   Identification of target tissue glycosphingolipid receptors for uropathogenic, F1C-fimbriated Escherichia coli and its role in mucosal inflammation [J].
Bäckhed, F ;
Alsén, B ;
Roche, N ;
Ångström, J ;
von Euler, A ;
Breimer, ME ;
Westerlund-Wikström, B ;
Teneberg, S ;
Richter-Dahlfors, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (20) :18198-18205
[5]  
BERGER H, 1982, J BACTERIOL, V152, P1241
[6]  
BOEN JR, 1965, INVESTIG UROL, V15, P468
[7]   Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract [J].
Connell, H ;
Agace, W ;
Klemm, P ;
Schembri, M ;
Marild, S ;
Svanborg, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) :9827-9832
[8]  
Connell H, 1996, ADV EXP MED BIOL, V408, P73
[9]   Pilot trial of bacterial interference for preventing urinary tract infection [J].
Darouiche, RO ;
Donovan, WH ;
Del Terzo, M ;
Thornby, JI ;
Rudy, DC ;
Hull, RA .
UROLOGY, 2001, 58 (03) :339-344
[10]  
EDEN CS, 1976, LANCET, V2, P490